Chinese scientist makes quality visit to USP; DPT overhauls Sterile & Specialty plant in NJ;

> Under its visiting scientist program for quality standards, the U.S. Pharmacopeial Convention is hosting Minghao Zhou from China's Zhejiang Provincial Institute for Food & Drug Control. Article

> A micro-lab and Class A filling suites, Class B and C support suites, and Class D component-prep areas are part of a $30 million expansion and infrastructure overhaul to DPT Laboratories' Center of Excellence for Sterile & Specialty Products in Lakewood, N.J. Release

> Roche NimbleGen, part of the drug giant's diagnostic division, is taking a GMP approach to its high-density DNA microarrays in an effort that will span development through manufacturing. Release

> The Ceelox ID Server, a network biometric security solution that works in conjunction with Honeywell POMS and Citrix, aims at "precise and automated processing and control" in pharma manufacturing ops. Release

> Zimbabwe's only listed pharmaceutical company, CAPS, has resumed production at its refurbished plant in Harare. Article

 

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.